Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro …

R Nieuwlaat, SB Olsson, GYH Lip, AJ Camm… - American heart …, 2007 - Elsevier
BACKGROUND: The Euro Heart Survey showed that antithrombotic treatment in patients
with atrial fibrillation (AF) was moderately tailored to the 2001 American College of …

Management of chronic heart failure guided by individual N-terminal pro–B-type natriuretic peptide targets: results of the PRIMA (Can PRo-brain-natriuretic peptide …

LWM Eurlings, PEJ van Pol, WE Kok, S van Wijk… - Journal of the American …, 2010 - jacc.org
Objectives: The purpose of this study was to assess whether management of heart failure
(HF) guided by an individualized N-terminal pro–B-type natriuretic peptide (NT-proBNP) …

[HTML][HTML] Early or delayed cardioversion in recent-onset atrial fibrillation

NAHA Pluymaekers, EAMP Dudink… - … England Journal of …, 2019 - Mass Medical Soc
Background Patients with recent-onset atrial fibrillation commonly undergo immediate
restoration of sinus rhythm by pharmacologic or electrical cardioversion. However, whether …

Atrial fibrillation and heart failure in cardiology practice: reciprocal impact and combined management from the perspective of atrial fibrillation: results of the Euro Heart …

R Nieuwlaat, LW Eurlings, JG Cleland… - Journal of the American …, 2009 - jacc.org
Objectives: Our aim was to identify shortcomings in the management of patients with both
atrial fibrillation (AF) and heart failure (HF). Background: AF and HF often coincide in …

Delays in the treatment of patients with acute coronary syndrome: Focus on pre-hospital delays and non-ST-elevated myocardial infarction

KA Mol, BM Rahel, JG Meeder… - International journal of …, 2016 - Elsevier
Delays in patients suspected of acute coronary syndrome (ACS) should be kept as short as
possible to reduce complications and mortality. In this review we discuss the substantial pre …

[HTML][HTML] The role of glucose lowering agents on restenosis after percutaneous coronary intervention in patients with diabetes mellitus

CPH Lexis, BM Rahel, JG Meeder, F Zijlstra… - Cardiovascular …, 2009 - Springer
Introduction The prevalence of diabetes is increasing rapidly, and individuals with diabetes
are at high risk for cardiovascular disorders. Subsequently the percentage of patients with …

[HTML][HTML] Outpatient management of patients with angina with no obstructive coronary arteries: how to come to a proper diagnosis and therapy

JG Meeder, MJ Hartzema-Meijer… - Frontiers in …, 2021 - frontiersin.org
Two-thirds of women and one-third of men who undergo a clinically indicated coronary
angiography for stable angina, have no obstructive coronary artery disease (CAD). Coronary …

[HTML][HTML] Cost effectiveness of the angiotensin receptor neprilysin inhibitor sacubitril/valsartan for patients with chronic heart failure and reduced ejection fraction in the …

IC Ramos, MM Versteegh, RA de Boer, JMA Koenders… - Value in Health, 2017 - Elsevier
Objectives To describe the adaptation of a global health economic model to determine
whether treatment with the angiotensin receptor neprilysin inhibitor LCZ696 is cost effective …

Point-of-care high-sensitivity troponin-I analysis in capillary blood for acute coronary syndrome diagnostics

AL Bruinen, LDS Frenk, F de Theije… - Clinical Chemistry and …, 2022 - degruyter.com
Objectives Patients with acute coronary syndrome (ACS) should be referred promptly to the
hospital to reduce mortality and morbidity. Differentiating between low-risk and high-risk …

Routine follow-up after pacemaker implantation: frequency, pacemaker programming and professionals in charge

JWM van Eck, NM van Hemel, WG de Voogt… - Europace, 2008 - academic.oup.com
Aims To describe current evidence of the frequency, contents, and involved professionals of
the routine follow-up visits in patients who have received a pacemaker (PM). Methods and …